David Ziegler

50PUBLICATIONS

440CO-AUTHORS

Molecular targetsGene and molecular therapyCancer geneticsEpigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (50)

Sort by Publication Date:

|May 19, 2026

Precision-guided therapy in H3K27-altered diffuse midline glioma.

|Apr 30, 2026

A new hope: Clinical advances in targeted therapies for pediatric diffuse midline glioma.

|Apr 27, 2026

Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young.

|Apr 24, 2026

Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial.

|Mar 27, 2026

RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition.

Samuel E Ross, Holly Holliday, Eyden Wang

|Mar 18, 2026

Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.

Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh

Pageof 9

Frequent Collaborators

14 joint publications

Chelsea Mayoh

13 joint publications

Loretta M S Lau

11 joint publications

Mark J Cowley

Jordan R Hansford

Claire E Wakefield

Kate Hetherington

Maria Tsoli

Paul G Ekert

Dong-Anh Khuong-Quang

7 joint publications

Nicholas G Gottardo

Frequent Collaborators

14 joint publications

Chelsea Mayoh

13 joint publications

Loretta M S Lau

11 joint publications

Mark J Cowley

9 joint publications

Jordan R Hansford